Sun Pharma Advanced Research Files Application to Stock Exchanges for Reclassification Status Change
Sun Pharma Advanced Research Company Ltd. (SPARC) has submitted an application to stock exchanges seeking approval for its reclassification status, moving from the 'Promoter Group' category to the 'Public' category. This move follows earlier communications regarding the company's corporate structure changes, dated July 27, 2026 and August 10, 2026.The application, submitted on August 13, 2026, aims to obtain no objection or approval from the stock exchanges concerning this change in classification, as outlined by relevant regulations pertaining to listing obligations.
SPARC's move reflects a significant procedural step intended to formalize its public standing within the financial markets. The company has been engaging with regulatory matters related to status changes through these filings to ensure complete alignment with market requirements.
SPARC Stock Price Movement
Today, the stock of Sun Pharma Advanced Research Company Limited rallied, closing at ₹204.28 after gaining 1.38%. The equity traded within an intraday range spanning from ₹201 to ₹205.43 amid a total volume of 483,907 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.